S1 Guideline on Post-COVID/Long-COVID

September 2021 in “ Pneumologie ”

Andreas Rembert Koczulla, Tobias Ankermann, Uta Behrends, Peter Berlit, Sebastian Böing, Folke Brinkmann, , R Glöckl, Christian Gogoll, Thomas Hummel, Juliane Kronsbein, , Eva M.J. Peters, Michael Pfeifer, Thomas Platz, Mathias W. Pletz, Georg Pongratz, Frank Powitz, Klaus F. Rabe, Carmen Scheibenbogen, Andreas Stallmach, Michael Stegbauer, H. O. Wagner, Cornelius F. Waller, Hubert Wirtz, Andreas M. Zeiher, Ralf Harun Zwick

Studysummary This review discusses the development of an interdisciplinary guideline on Post-COVID/Long-COVID symptoms, diagnostics, and therapies by the Deutsche Gesellschaft für Pneumologie, reporting no new results but highlighting ongoing updates based on emerging knowledge. Our plain-language summary of this paper — not a Tressless recommendation.

The S1 guideline on Post-COVID/Long-COVID, initiated by the German Respiratory Society, was developed through an interdisciplinary approach based on the knowledge available at the time. It provided clinical recommendations on symptoms, diagnostic approaches, and therapies for Post-COVID/Long-COVID. The guideline aimed to be practical and was designed to be continuously updated and adapted by the author team as new knowledge emerged.

View this study on thieme-connect.de →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Public Interest in Dermatologic Symptoms, Conditions, Treatments, and Procedures During the COVID-19 Pandemic: Insights from Google Trends

18 citations , February 2021 in “Dermatologic therapy”

This study found that the COVID-19 pandemic significantly altered public interest in dermatologic conditions and treatments, with decreased interest in skin cancers but increased interest in issues like dry skin and hand eczema.

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

114 citations , January 2021 in “medRxiv (Cold Spring Harbor Laboratory)”

This meta-analysis estimated that around 80% of patients who had COVID-19 experienced at least one long-term symptom, with fatigue being the most common reported effect.

research What Can Hair Tell Us About COVID-19?

27 citations , December 2020 in “Experimental Dermatology”

This study reported that COVID-19 was causally associated with postinfectious hair shedding, which varied with disease severity, but hair completely recovered.

research The Inflammatory Aspect of Male and Female Pattern Hair Loss

9 citations , November 2020 in “Journal of Inflammation Research”

This perspective highlights the role of inflammation in male and female pattern hair loss and its implications for developing future therapeutic options.

Are the Cutaneous Manifestations During or Due to SARS-CoV-2 Infection/COVID-19 Frequent or Not? Revision of Possible Pathophysiologic Mechanisms

research Are the Cutaneous Manifestations During or Due to SARS-CoV-2 Infection/COVID-19 Frequent or Not? Revision of Possible Pathophysiologic Mechanisms

82 citations , June 2020 in “Inflammation Research”

This review discusses the complex pathophysiological and clinical aspects of COVID-19, including dermatological findings and their association with SARS-CoV-2 infection but reports no new clinical results.